Latest Breaking News On - Sorbents corporation - Page 4 : comparemela.com

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation -Today at 11:33 am

In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survivalPRINCETON, N.J., Sept. 11, 2023 CytoSorbents.

Phillip chanSandra lindstedtKathleen blochMassimo boffiniEuropean unionCytosorbents corporationLund university hospitalCity of healthExtracorporeal life support organizationUnited network of organ sharingScience university hospital of turinUniversity hospital zurichUniversity of turinNature communicationsSorbents corporationOrgan transplantation

Cytosorbents : Q2 2023 Press Release -Today at 04:45 am

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results Q2 2023 Total Revenue was $9.4 million, an 11% increase from $8.5.

Humedic limaxMichael batorEli lillyKathy blochPhillip chanDaiichi sankyoAl krausasHealth canadaHealthcare research at jennison associatesPartner of quartz advisory groupCytosorbents corporationCytosorbents reports second quarterSorbents corporationOperating highlightsSafety monitoring boardAlexanderd amico

Cytosorbents : Q4 and Full Year 2022 Press Release -Today at 04:45 am

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales .

France generalRichard whitlockIrina kulinetsPhillip chanVince capponiJim komsaCanada researchCytosorbents corporationHealth canadaEuropean association for cardioFresenius medical careInternational cytosorb registryEuropean society of cardiologyCytosorbents reports fourth quarterFull yearSorbents corporation

CytoSorbents Announces Resignation of Chief Financial

PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in.

Alexander damicoKathleen blochCytosorbents corporationEuropean unionSorbents corporationAlexanderd amicoChief financial officerInterim chief financial officerDevice designationsPrivate securities litigation reform actAnnual reportQuarterly reportsSorbents contactNasdaq ctsoChief financial officerBlood purification

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D Amico

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D Amico
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alexander damicoKathleen blochCytosorbents corporationEuropean unionSorbents corporationAlexanderd amicoChief financial officerInterim chief financial officerDevice designationsPrivate securities litigation reform actAnnual reportQuarterly reportsSorbents contact